About Event
The Ultimate Industry Forum to Discuss Market Access Strategies for
Obesity & CVRM Therapeutics
Despite the huge commercial success of GLP-1s in recent years, market access, pricing and reimbursement strategies for these ‘wonder drugs’ are becoming increasingly complicated. High costs, shortages and payer concerns over clinical and economic value are hindering the availability of anti-obesity medications to the patients that need them most.
The inaugural Market Access for Obesity & CVRM Summit is uniting the crucial stakeholders to tackle these challenges, namely late clinical and commercial stage biopharma, government authorities, commercial payers, policy makers, academics, advocacy groups and market access service providers.
Join Your Peers to...
Put yourself in the room with these stakeholders to progress your market access strategy, forge connections with industry leaders, and leverage key insights across the following themes:
Empower Your Team in
Market Access Excellence
Gain practical insights for launching products with a dual brand strategy for reimbursement optimization, patient population segmentation and strategic tailored messaging.
Evaluate Effective
Payment Model
Dive into the intricacies of different payment models to understand how they affect affordability, likelihood of reimbursement, value-based and cost-containment for new-market entrants in the obesity field.
Advance Reimbursement
Strategies
Understand how reimbursement models are the key drivers in improving affordability, adherence, budget predictions and ultimately, improved clinical outcomes for patients.
Assess Value & Generate Evidence
With assessing value and generating evidence arguably the most important aspects of market access, the RWE and HEOR strategy sessions will dive into increasing payer confidence, formulary inclusion strategies and smooth pricing negotiations.
Stay Up to Speed on Policy Updates
At this turbulent time, policies in the US healthcare system, specifically with obesity medications, are hard to keep up with. Join the dedicated health policy sessions for deep dives into the IRA and TROA to gain a better understanding of potential access bottlenecks and how to deal with them.
Learn from industry leaders, engage in meaningful discussions, and make new connections with decision makers to streamline your market access and commercialization strategies.
Who Will You Meet?
The Market Access for Obesity & CVRM Therapeutics Summit is dedicated to progressing market access conversations through open and constructive collaboration between multiple stakeholders. Uniting an audience of industry experts to facilitate forward-thinking discussions, leading to the formation of new relationships and increased knowledge sharing in a challenging field.
This is the only industry-led forum dedicated to helping all stakeholders unlock access to anti-obesity and wider CVRM therapeutics.
With representatives from Pricing & Reimbursement, Market Access, Marketing Commercial, Government Affairs, Policy, Real-World Evidence, and HEOR domains, this meeting will provide actional insights for all attendees, whether they are looking to establish a market access department, launch successfully, or bolster the commercial performance of in-market therapies.
What Your Peers Have to Say:
